US Stock MarketDetailed Quotes

SNSE Sensei Biotherapeutics

Watchlist
  • 0.983
  • -0.017-1.71%
Close Apr 18 16:00 ET
24.64MMarket Cap-805P/E (TTM)

About Sensei Biotherapeutics Company

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Company Profile

SymbolSNSE
Company NameSensei Biotherapeutics
Listing DateFeb 4, 2021
Issue Price19.00
Founded1999
CEOMr. John Celebi
MarketNASDAQ
Employees27
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1405 Research Boulevard`,Suite 125
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-240-243-8000
Websitehttp://senseibio.com

Company Executives

  • Name
  • Position
  • Salary
  • John Celebi
  • President, Chief Executive Officer and Director
  • 1.57M
  • Patrick Gallagher
  • Chief Business Officer
  • --
  • Edward Van der Horst
  • Chief Scientific Officer
  • 654.40K
  • William R. Ringo, Jr
  • Chairman of the Board
  • 200.08K
  • Kristian Humer
  • Independent Director
  • 75.03K
  • Dr. James Peyer, PhD
  • Independent Director
  • 88.93K
  • Bob Holmen
  • Independent Director
  • 87.41K
  • Dr. Jessie M. English, PhD
  • Independent Director
  • 79.03K
  • Dr. Deneen Vojta
  • Independent Director
  • 81.61K
  • Thomas G. Ricks
  • Independent Director
  • 93.60K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg